Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Acorda Therapeutics, Inc. (ACOR)

« Back to company index

ACOR Chatter Timeline

Stock Ticker for ACOR

Most Active Tweeters for ACOR

UserTweets
@thefinreviewer 9
@whatsonthorold2 8
@bulletin_en 8
@mmahotstuff1 7
@AmericanBanking 7

Recent Tweets for ACOR

dailypoliticaln @dailypoliticaln
Acorda Therapeutics Inc $ACOR Receives $22.33 Consensus Price Target from Analysts https://t.co/NXOlTSaRyW
April 19th 2019, 12:04pm
ZolmaxNews @ZolmaxNews
Analysts Set Acorda Therapeutics Inc $ACOR Price Target at $22.33 https://t.co/JXFCJsZyal
April 19th 2019, 11:04am
TickerReport @TickerReport
Acorda Therapeutics $ACOR Rating Lowered to Strong Sell at BidaskClub https://t.co/71wDbfdJBL
April 19th 2019, 4:04am
WatchlistN @WatchlistN
Acorda Therapeutics $ACOR Cut to Strong Sell at BidaskClub https://t.co/QYSZUsNcxW
April 19th 2019, 4:04am
registrarjourn @registrarjourn
Comparing Champions Oncology $CSBR & Acorda Therapeutics $ACOR https://t.co/LjYHwc7nLa
April 19th 2019, 1:04am
EnterpriseLeade @EnterpriseLeade
Comparing Champions Oncology $CSBR & Acorda Therapeutics $ACOR https://t.co/f8RBaWoBix
April 19th 2019, 1:04am
thefinreviewer @thefinreviewer
Kiniksa Pharmaceuticals Ltd. $ACOR Comparison side by side https://t.co/Tk2bsWUBMi
April 18th 2019, 6:04pm
whatsonthorold2 @whatsonthorold2
This is what analysts have to say about Acorda Therapeutics, Inc. $ACOR after last week. https://t.co/QNUMX5bcJ7
April 18th 2019, 4:04pm
bibeypost_stock @bibeypost_stock
Acorda Therapeutics Inc $ACOR’s Trend Unknown, Especially After Increased Shorts https://t.co/2UZ8xfDUIY
April 18th 2019, 11:04am
BlogYomi @BlogYomi
First Fiduciary Investment Counsel Has Increased Walt Disney Co $DIS Stake; Acorda Therapeutics, Inc. $ACOR Covered… https://t.co/FCo1Q9jLzh
April 18th 2019, 9:04am
newswithvalue @newswithvalue
$ACOR: Acorda First Quarter 2019 Update: Webcast/Conference Call …: https://t.co/XzR16WOudF
April 18th 2019, 7:04am
Allstocknews @Allstocknews
$ACOR Acorda - Acorda Provides Financial and Pipeline Update for First Quarter 2019 From our Stock News Alerts App
April 18th 2019, 7:04am
Allstocknews @Allstocknews
$ACOR Acorda - Acorda First Quarter 2019 Update: Webcast/Conference Call Scheduled for May 2, 2019 From our Stock News Alerts App
April 18th 2019, 7:04am
stocknewstimes @stocknewstimes
Neuralstem $CUR & Acorda Therapeutics $ACOR Head-To-Head Contrast https://t.co/ZgWgryfoCo
April 18th 2019, 5:04am
thefinreviewer @thefinreviewer
Comparing of Aldeyra Therapeutics Inc. $ACOR https://t.co/2tOzbCIVWv
April 17th 2019, 10:04pm
whatsonthorold2 @whatsonthorold2
Acorda Therapeutics, Inc. $ACOR Analysts See $-0.82 EPS https://t.co/vQpaDK1Md4
April 17th 2019, 4:04pm
thefinreviewer @thefinreviewer
Intrexon Corporation $ACOR Comparing side by side https://t.co/vaoUqGqc43
April 17th 2019, 11:04am
ConsumerFeed @ConsumerFeed
Acorda Therapeutics $ACOR Reaches New 12-Month Low at $11.98 https://t.co/0kLnHRjzT6
April 17th 2019, 11:04am
LargeVoidBot @LargeVoidBot
09:43 New 52wk Lows: $ACOR
April 17th 2019, 9:04am
dailypoliticaln @dailypoliticaln
Acorda Therapeutics $ACOR Lowered to Strong Sell at BidaskClub https://t.co/zpdlYUk1N1
April 17th 2019, 5:04am
ZolmaxNews @ZolmaxNews
BidaskClub Lowers Acorda Therapeutics $ACOR to Strong Sell https://t.co/7yczGRRXgc
April 17th 2019, 5:04am
UlmHi @UlmHi
Forward Pharma A/S $ACOR https://t.co/TZbJi5vdHl
April 16th 2019, 6:04pm
ThisLincolnian @ThisLincolnian
Acorda Therapeutics Inc $ACOR Expected to Announce Earnings of -$0.97 Per Share https://t.co/ipDArsMuYr
April 16th 2019, 6:04pm
bbnsnews @bbnsnews
$36.63 Million in Sales Expected for Acorda Therapeutics Inc $ACOR This Quarter https://t.co/cZy5HolxO7
April 16th 2019, 6:04pm
stocknewstimes @stocknewstimes
Critical Survey: Acorda Therapeutics $ACOR versus Champions Oncology $CSBR https://t.co/R2DXesmHMy
April 16th 2019, 4:04pm
AmericanBanking @AmericanBanking
Critical Survey: Acorda Therapeutics $ACOR versus Champions Oncology $CSBR https://t.co/ryYeh7mlNZ #stocks
April 16th 2019, 4:04pm
bibeypost_stock @bibeypost_stock
Acorda Therapeutics, Inc. $ACOR Analysts See $-0.82 EPS https://t.co/AY3FHFzn0Y
April 16th 2019, 3:04pm
macondailynews @macondailynews
Acorda Therapeutics Inc $ACOR Receives Average Recommendation of “Hold” from Brokerages https://t.co/yNXXVxPAnC
April 16th 2019, 12:04pm
TheMarketsDaily @TheMarketsDaily
Acorda Therapeutics Inc $ACOR Receives Consensus Recommendation of “Hold” from Brokerages https://t.co/ctQhCSiuz6
April 16th 2019, 12:04pm
AmericanBanking @AmericanBanking
Acorda Therapeutics Inc $ACOR Receives Average Recommendation of “Hold” from Brokerages https://t.co/9Dl1ZgFmDH #stocks
April 16th 2019, 12:04pm
AmericanBanking @AmericanBanking
Equities Research Analysts’ Downgrades for April, 16th $ACOR, ALGT, ALK, ALNY, AM, ARRY, ATNI, BIDU, CBSH, EQIX… https://t.co/GDFNzT6mKz
April 16th 2019, 10:04am
ThisLincolnian @ThisLincolnian
Equities Research Analysts’ Downgrades for April, 16th $ACOR, ALGT, ALK, ALNY, AM, ARRY, ATNI, BIDU, CBSH, EQIX https://t.co/IEpK4yzrpv
April 16th 2019, 10:04am
macondailynews @macondailynews
BidaskClub Downgrades Acorda Therapeutics $ACOR to Strong Sell https://t.co/bVbd0qjD0y
April 16th 2019, 9:04am
dakotafinancial @dakotafinancial
BidaskClub Downgrades Acorda Therapeutics $ACOR to Strong Sell https://t.co/EtQlxKu1aJ
April 16th 2019, 9:04am
registrarjourn @registrarjourn
Contrasting Acorda Therapeutics $ACOR & Neuralstem $CUR https://t.co/zey2OMOgLj
April 16th 2019, 2:04am
EnterpriseLeade @EnterpriseLeade
Contrasting Acorda Therapeutics $ACOR & Neuralstem $CUR https://t.co/ahAHn5QRwr
April 16th 2019, 2:04am
dispatchtribune @dispatchtribune
Neuralstem $CUR & Acorda Therapeutics $ACOR Critical Review https://t.co/MEJ3IGBWEF
April 16th 2019, 2:04am
thefinreviewer @thefinreviewer
Arrowhead Pharmaceuticals Inc. $ACOR https://t.co/pMw9sDbmFZ
April 16th 2019, 12:04am
bbnsnews @bbnsnews
Acorda Therapeutics $ACOR Hits New 52-Week Low at $11.98 https://t.co/WE3HPg740u
April 15th 2019, 6:04pm
mmahotstuff1 @mmahotstuff1
It's been a crucial week for Acorda Therapeutics, Inc. $ACOR; here's what analysts have to say. https://t.co/QtrYNCbQXI
April 15th 2019, 4:04pm
bulletin_en @bulletin_en
On Apr, 15 Acorda Therapeutics, Inc. $ACOR Sets 1-Year Low at $11.94 https://t.co/UDJcTvXaNt
April 15th 2019, 2:04pm
BlogYomi @BlogYomi
Acorda Therapeutics, Inc. $ACOR Reaches $12.02 Yearly Low; Foresite Capital Management Ii Has Cut Biodelivery Scien… https://t.co/25Gazz3dd3
April 15th 2019, 12:04pm
BlogYomi @BlogYomi
Clarivest Asset Management Lifted Its Stake in Acorda Therapeutics $ACOR by $497,250; Douglass Winthrop Advisors Ha… https://t.co/NwREPa3Ghw
April 15th 2019, 5:04am
whatsonthorold2 @whatsonthorold2
$-0.82 EPS Expected for Acorda Therapeutics, Inc. $ACOR https://t.co/ATkdsJcn8M
April 14th 2019, 5:04pm
bulletin_en @bulletin_en
Acorda Therapeutics, Inc. $ACOR Weekly Ratings on Apr 14, 2019 https://t.co/7OkcUCydmV
April 14th 2019, 4:04pm
TheMarketsDaily @TheMarketsDaily
Analysts Expect Acorda Therapeutics Inc $ACOR Will Post Earnings of -$0.97 Per Share https://t.co/rrAdyThWAj
April 14th 2019, 11:04am
SwingTradeBot @SwingTradeBot
Recent $ACOR technical alerts: New 52 Week Closing Low plus 7 more alerts... https://t.co/1adF6fMty1
April 14th 2019, 11:04am
mmahotstuff1 @mmahotstuff1
EPS for Acorda Therapeutics, Inc. $ACOR Expected At $-0.82 https://t.co/Wnq4lnycfv
April 13th 2019, 9:04pm
whatsonthorold2 @whatsonthorold2
Acorda Therapeutics, Inc. $ACOR Analysts See $-0.82 EPS https://t.co/laNV5RVYNH
April 13th 2019, 9:04pm
1MinuteStock @1MinuteStock
Wondering about risks of $ACOR? The 21-day volatility is 10.54% https://t.co/BStDYDF4A9
April 13th 2019, 6:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.